menu toggle

Download: The evolution of value assessment in the US: considerations and controversies 

More insights from Xcenda

Rainbow-Abstract

Insight

Essential guide to cell and gene therapy (CGT)  commercialization


AmerisourceBergen
April 2024

ThinkLive-web-hero-background-1200x800

Insight

Pharma in the field: Barrett's story


Xcenda
February 2024

Vials

Insight

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond


AmerisourceBergen
January 2024